VivoSeq
Other

Fetal Distress

2

Pipeline Programs↗

1

Active Trials↗

2

Companies Involved↗

Fetal distress is an early-stage landscape with 2 programs across 2 companies. The most active players are Viatris Specialty LLC, Sanofi. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

V

Viatris Specialty LLC

1 program

ApprovedSanofi logo

Sanofi

1 program

Preclinical

Pipeline

Programs by Phase

Preclinical1

Terbutaline

Sanofi

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved1

Sildenafil

Viatris Specialty LLC

Analysis

Trial Status

3

clinical trials

Completed2 · 67%
Recruiting1 · 33%

Clinical Trials

Trial Activity

Sildenafil Citrate and Intrapartum Fetal Distress
Completed·—·Phase 4·NCT04325243·410 enrolled
Acute Tocolysis With Terbutaline for Suspected Fetal Distress
Completed·HHospital Kemaman·N/A·NCT05326269·100 enrolled
Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device
Recruiting·BBalgrist University Hospital·N/A·NCT06813859·20 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)